NexGel, Inc. (NASDAQ:NXGL – Get Free Report) Director Steven Mark Glassman acquired 4,546 shares of the business’s stock in a transaction dated Tuesday, November 10th. The stock was purchased at an average cost of $5.50 per share, with a total value of $25,003.00. Following the transaction, the director owned 12,379 shares of the company’s stock, valued at approximately $68,084.50. The trade was a 58.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
NexGel Trading Up 2.4%
Shares of NXGL traded up $0.09 on Friday, hitting $3.88. 13,639 shares of the stock traded hands, compared to its average volume of 41,562. The company has a quick ratio of 0.27, a current ratio of 0.43 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $1.90 million, a P/E ratio of -0.27 and a beta of 0.81. The stock’s 50 day moving average is $4.51 and its two-hundred day moving average is $11.31. NexGel, Inc. has a 1 year low of $3.00 and a 1 year high of $41.20.
NexGel (NASDAQ:NXGL – Get Free Report) last released its earnings results on Friday, August 14th. The company reported ($8.00) EPS for the quarter, missing the consensus estimate of ($2.40) by ($5.60). The firm had revenue of $3.69 million during the quarter, compared to analysts’ expectations of $4.32 million. NexGel had a negative return on equity of 121.18% and a negative net margin of 51.26%. As a group, sell-side analysts predict that NexGel, Inc. will post -18.80 earnings per share for the current year.
Institutional Trading of NexGel
A hedge fund recently bought a new stake in NexGel stock. Empery Asset Management LP bought a new position in shares of NexGel, Inc. (NASDAQ:NXGL – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 90,000 shares of the company’s stock, valued at approximately $3,474,000. Empery Asset Management LP owned approximately 0.98% of NexGel as of its most recent filing with the Securities and Exchange Commission. 2.21% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on NXGL shares. Zacks Research upgraded NexGel to a “hold” rating in a report on Friday, October 2nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of NexGel in a research note on Friday, October 9th. Finally, Maxim Group lowered NexGel from a “buy” rating to a “hold” rating in a research note on Monday, August 24th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, NexGel currently has an average rating of “Reduce” and a consensus target price of $40.00.
View Our Latest Stock Report on NexGel
About NexGel
NexGel, Inc. (NASDAQ:NXGL) develops and manufactures high-water-content hydrogel products for medical, consumer and other specialized applications. The company uses proprietary formulations and electron-beam processing to produce flexible, skin-compatible products designed to retain moisture and provide cooling, cushioning or conductive properties. Its product applications include wound care, burn and surgical care, pain management, medical diagnostics and personal wellness. NexGel supplies hydrogel sheets, patches and related components used in products such as wound dressings, therapeutic pads and medical electrodes.
Featured Stories
- Five stocks we like better than NexGel
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
